HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Voluntary reporting update

This article was originally published in The Rose Sheet

Executive Summary

Number of new submissions to FDA's Cosmetic Voluntary Reporting Program estimated at 1,920 annually, agency says in July 8 Federal Register notice. Additional 75 amendments and 20 notices of discontinuance also are anticipated, FDA notes. Larger cosmetic companies have resumed participation in CVRP program since it was discontinued due to lack of funding in 1998 and reinstated in 1999, but smaller companies are "lagging," agency says. Program's estimated 987-hour maintenance burden on FDA is 60% that reported in 1999, agency says. Under CVRP, FDA requests cosmetic manufacturers submit ingredient statements and reported adverse reactions for their products...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010455

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel